Mean weight loss of 19.2% at 6 mg with no plateau in 48-week Phase 3 trial – – Favorable safety profile consistent with other ...

China’s exports regained momentum in June as firms rushed out orders to capitalise on a fragile tariff truce between Beijing ...

U.S.-based Kailera Therapeutics and Chinese firm Jiangsu Hengrui Pharmaceuticals' experimental weight-loss drug has helped overweight patients lose up to 17.7% of body weight in a late-stage study in ...

China's rapid rise in electric vehicles, renewables, and biotechnology is reshaping global tech dominance through state ...

A meteorologist said the temperatures in northern cities are resembling parts in the south. Read more at straitstimes.com.

Innovent Biologics, the first Chinese firm to gain approval for a GLP-1 weight loss and diabetes drug, has partnered with JD Health for online distribution.

On Tuesday, Beijing’s National Bureau of Statistics (NBS) said the Chinese economy grew 5.2 percent from April to June, matching a prediction by an AFP survey of analysts and topping an official ...

The technology has seen speeds that outpace commercial jet flights, which usually travel at around 570 miles per hour.

Urban planning efforts include the “Green City Expansion Plan,” featuring a “four vertical and four horizontal” network of ...

Innovent Biologics, the first Chinese company to win regulatory approval to sell a GLP-1 drug for weight loss and diabetes, ...

On July 12, 2025, in Jiangsu, China, @Jiūyuèmiē shared a video of a cat standing on a rock in the middle of a small canal.